Baricitinib

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2220 publications

The role of monoclonal antibodies in the treatment of lupus nephritis.

The role of monoclonal antibodies in the treatment of lupus nephritis.

Journal: Expert opinion on biological therapy

Published: April 07, 2026

Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study.

Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study.

Journal: The Journal of dermatological treatment

Published: April 01, 2026

Human Serum Albumin-coated macromolecular niosomes for enhanced immunotherapeutic efficacy in rheumatoid arthritis: optimization, characterization and in-vivo assessment.

Human Serum Albumin-coated macromolecular niosomes for enhanced immunotherapeutic efficacy in rheumatoid arthritis: optimization, characterization and in-vivo assessment.

Journal: Journal of drug targeting

Published: March 28, 2026

Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience.

Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience.

Journal: Immunological medicine

Published: March 27, 2026

Successful Treatment of Acquired Idiopathic Generalized Anhidrosis With Baricitinib.

Successful Treatment of Acquired Idiopathic Generalized Anhidrosis With Baricitinib.

Journal: JAMA dermatology

Published: March 25, 2026

Stepwise topical corticosteroid and dexamethasone rescue strategy enhances baricitinib outcomes in severe alopecia areata: real-life clinical experience.

Stepwise topical corticosteroid and dexamethasone rescue strategy enhances baricitinib outcomes in severe alopecia areata: real-life clinical experience.

Journal: European journal of dermatology : EJD

Published: March 23, 2026

Advances in the use of Janus kinase inhibitors.

Advances in the use of Janus kinase inhibitors.

Journal: Current opinion in rheumatology

Published: March 17, 2026

Cardiovascular risk and JAK inhibitor for the treatment of spondyloarthritis: A systematic review protocol.

Cardiovascular risk and JAK inhibitor for the treatment of spondyloarthritis: A systematic review protocol.

Journal: La Tunisie medicale

Published: March 15, 2026

IL-6 Receptor Antagonists and Severe Post-COVID-19 Outcomes: An Emulated Target Trial.

IL-6 Receptor Antagonists and Severe Post-COVID-19 Outcomes: An Emulated Target Trial.

Journal: medRxiv : the preprint server for health sciences

Published: March 13, 2026

Effective treatment of alopecia areata and psoriasis with baricitinib.

Effective treatment of alopecia areata and psoriasis with baricitinib.

Journal: The British journal of dermatology

Published: March 11, 2026

Experimental JAK inhibitors: the current, present, and future in graft-versus-host disease management?

Experimental JAK inhibitors: the current, present, and future in graft-versus-host disease management?

Journal: Expert opinion on investigational drugs

Published: March 11, 2026

Relapse of Kimura's Disease After Discontinuation of Baricitinib and Rapid Response to Retreatment: A Follow-Up Case Report.

Relapse of Kimura's Disease After Discontinuation of Baricitinib and Rapid Response to Retreatment: A Follow-Up Case Report.

Journal: The Journal of dermatology

Published: March 11, 2026

Showing 1-12 of 2,220

Last Updated: 04/28/2026